Literature DB >> 34784527

The emerging neurological spectrum of AARS2-associated disorders.

Sahyli Perez Parra1, Stephan H Heckers2, William R Wilcox3, Colin David Mcknight4, H A Jinnah5.   

Abstract

BACKGROUND: The AARS2 gene encodes a mitochondrial alanyl-transfer RNA synthetase. Defects in this gene have been linked with autosomal recessive inheritance of a variety of different clinical phenotypes. CASE: A 13 year-old boy developed behavioral and psychiatric problems following a mild head injury. At age 21 he developed tremor, parkinsonism, and eye nystagmus. MRI revealed white matter changes consistent with a leukoencephalopathy. Genetic studies revealed two pathogenic mutations in the AARS2 gene (c.647dupG and c.595C > T). LITERATURE REVIEW: Only 47 cases of AARS2-associated disorders have been reported, with equal numbers of males and females, and age at onset ranging from infancy to 44 years. The most common clinical problems include movement disorders (71%), cognitive impairment (67%), corticospinal signs (64%), behavioral or psychiatric features (46%), and eye signs (34%). Imaging evidence suggestive of leukoencephalopathy is common, but not invariant. Premature ovarian failure is frequent in females, but not universal.
CONCLUSIONS: Defects in the AARS2 gene are a rare cause for a variety of movement disorders, often associated with brain imaging evidence suggestive of leukoencephalopathy.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  AARS2; Leukodystrophy; Movement disorders; Neuropsychiatric symptoms

Mesh:

Substances:

Year:  2021        PMID: 34784527      PMCID: PMC9100856          DOI: 10.1016/j.parkreldis.2021.10.031

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  27 in total

1.  Two Korean siblings with recently described ovarioleukodystrophy related to AARS2 mutations.

Authors:  J-M Lee; H-J Yang; J-H Kwon; W-J Kim; S-Y Kim; E-M Lee; J-Y Park; Y C Weon; S H Park; B-J Gwon; J-C Ryu; S-T Lee; H-J Kim; B Jeon
Journal:  Eur J Neurol       Date:  2017-04       Impact factor: 6.089

2.  New AARS2 Mutations in Two Siblings With Tremor, Downbeat Nystagmus, and Primary Amenorrhea: A Benign Phenotype Without Leukoencephalopathy.

Authors:  Giovanna De Michele; Daniele Galatolo; Maria Lieto; Luigi Maione; Sirio Cocozza; Filippo Maria Santorelli; Alessandro Filla
Journal:  Mov Disord Clin Pract       Date:  2020-07-07

3.  An adolescence-onset male leukoencephalopathy with remarkable cerebellar atrophy and novel compound heterozygous AARS2 gene mutations: a case report.

Authors:  Qing Dong; Ling Long; Yan-Yu Chang; Yan-Jun Lin; Mei Liu; Zheng-Qi Lu
Journal:  J Hum Genet       Date:  2018-04-17       Impact factor: 3.172

4.  AARS2 Compound Heterozygous Variants in a Case of Adult-Onset Leukoencephalopathy With Axonal Spheroids and Pigmented Glia.

Authors:  Danqing Wang; Meng Yu; Wei Zhang; Zhaoxia Wang; Yun Yuan
Journal:  J Neuropathol Exp Neurol       Date:  2018-11-01       Impact factor: 3.685

5.  Structural modeling of tissue-specific mitochondrial alanyl-tRNA synthetase (AARS2) defects predicts differential effects on aminoacylation.

Authors:  Liliya Euro; Svetlana Konovalova; Jorge Asin-Cayuela; Már Tulinius; Helen Griffin; Rita Horvath; Robert W Taylor; Patrick F Chinnery; Ulrike Schara; David R Thorburn; Anu Suomalainen; Joseph Chihade; Henna Tyynismaa
Journal:  Front Genet       Date:  2015-02-06       Impact factor: 4.599

Review 6.  Redefining the phenotype of ALSP and AARS2 mutation-related leukodystrophy.

Authors:  Rahul Lakshmanan; Matthew E Adams; David S Lynch; Justin A Kinsella; Rahul Phadke; Jonathan M Schott; Elaine Murphy; Jonathan D Rohrer; Jeremy Chataway; Henry Houlden; Nick C Fox; Indran Davagnanam
Journal:  Neurol Genet       Date:  2017-02-15

7.  Alanyl-tRNA Synthetase 2-Related Dementia with Selective Bilateral Frontal Cystic Leukoencephalopathy.

Authors:  Guilhem Carle; Alexandre Morin; Camille Noiray; Perrine Roy-Joly; Laurent Cohen; Richard Levy; Simon Samaan; Yann Nadjar
Journal:  J Clin Neurol       Date:  2018-07       Impact factor: 3.077

8.  Analysis of Mutations in AARS2 in a Series of CSF1R-Negative Patients With Adult-Onset Leukoencephalopathy With Axonal Spheroids and Pigmented Glia.

Authors:  David S Lynch; Wei Jia Zhang; Rahul Lakshmanan; Justin A Kinsella; Günes Altiokka Uzun; Merih Karbay; Zeynep Tüfekçioglu; Hasmet Hanagasi; Georgina Burke; Nicola Foulds; Simon R Hammans; Anupam Bhattacharjee; Heather Wilson; Matthew Adams; Mark Walker; James A R Nicoll; Jeremy Chataway; Nick Fox; Indran Davagnanam; Rahul Phadke; Henry Houlden
Journal:  JAMA Neurol       Date:  2016-12-01       Impact factor: 18.302

9.  Novel (ovario) leukodystrophy related to AARS2 mutations.

Authors:  Cristina Dallabona; Daria Diodato; Sietske H Kevelam; Tobias B Haack; Lee-Jun Wong; Gajja S Salomons; Enrico Baruffini; Laura Melchionda; Caterina Mariotti; Tim M Strom; Thomas Meitinger; Holger Prokisch; Kim Chapman; Alison Colley; Helena Rocha; Katrin Ounap; Raphael Schiffmann; Ettore Salsano; Mario Savoiardo; Eline M Hamilton; Truus E M Abbink; Nicole I Wolf; Ileana Ferrero; Costanza Lamperti; Massimo Zeviani; Adeline Vanderver; Daniele Ghezzi; Marjo S van der Knaap
Journal:  Neurology       Date:  2014-05-07       Impact factor: 9.910

10.  AARS2 leukoencephalopathy: A new variant of mitochondrial encephalomyopathy.

Authors:  Yi Tang; Qi Qin; Yi Xing; Dongmei Guo; Li Di; Jianping Jia
Journal:  Mol Genet Genomic Med       Date:  2019-01-31       Impact factor: 2.183

View more
  2 in total

Review 1.  The tRNA regulome in neurodevelopmental and neuropsychiatric disease.

Authors:  Jennifer Blaze; Schahram Akbarian
Journal:  Mol Psychiatry       Date:  2022-05-03       Impact factor: 15.992

Review 2.  Mitochondrial protein synthesis and the bioenergetic cost of neurodevelopment.

Authors:  Pernille Bülow; Anupam Patgiri; Victor Faundez
Journal:  iScience       Date:  2022-08-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.